Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

NCT04748705 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

422

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: IMC-1
DRUG: Placebo BID Tablet

Sponsor

Virios Therapeutics, Inc.